News

The International Conference on Research Infrastructures (ICRI) is the major professional forum for the global research infrastructure community and brings together policymakers, research institution leaders, facility operators, users and researchers, to discuss pressing topics of interest, trends and challenges facing research infrastructures around the world. The 2024 edition will be delivered by Australia’s national science agency, CSIRO (the Commonwealth Scientific and Industrial Research Organisation) and is held in Brisbane. ICRI 2024 will explore trends, challenges, and opportunities in research infrastructures globally.

More information on the ICRI 2024 website here.

The World Orphan Drug Congress Europe is the largest and most established orphan drug & rare disease event worldwide. Meet over 2000 attendees, hear from 250 leading speakers, and connect with 130 exhibitors as we bring together experts from the start-to-finish of orphan drugs. From regulation and policy to global pricing and gene therapy, the Congress has it covered. 

Attendees include the most senior individuals across the industry, including; R&D, Gene Therapy and Rare diseases, Precision/Personalised Medicine, Genetic Disorders, Patient Advocacy and Engagement, Associations in ATMPs, Investors, Regulatory Affairs Professionals, Governmental Bodies and many more …

• Conference: Covering cell and gene therapy, genetic testing, market access, real world evidence, orphan drugs policy and much more.
• Exhibition: 100+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions.
• Networking: Networking is at the heart of World Orphan Drug Congress. Our congress allows you to connect directly with thousands of pharma experts across 3 days of built-in 1-2-1 networking.

Join the World Orphan Drug Congress between 22-25th October 2024 in Barcelona!

More info and registration via the website.

To improve cancer treatment outcomes and advance the care of cancer patients, the canSERV consortium invites cancer researchers world-wide to apply for free access to cutting-edge transnational research services and training.

As part of the EU Cancer Mission, canSERV strives to accelerate oncology research to foster precision medicine for the benefit of patients across Europe. To this end, a budget of 600 000€ has been allocated for a new Challenge-driven Call for Service Provision “Revolutionising Cancer Patient Care: Innovative Approaches to Research and Clinical Trials for Improving Treatment Outcomes”. The canSERV project offers more than 400 innovative cancer research services. In this Challenge-Driven Call, a minimum of two services from the canSERV Service Catalogue should be requested. Training is considered a separate additional service.

To learn more about the projet and this call, please visit the canSERV website.

CRIGH is very pleased to announce that the seventh CRIGH General Assembly will be held on Tuesday 5 November 2024, and unites representatives from the global clinical research community.

This year the General Assembly will be organised as an online event from 12:00-14:00 (CET), and invitations to join the meeting as well as the draft agenda will be send out soon.

So mark your calenders, as we have impactful matters to discuss. See you then!

World Blood Donor Day (WBDD) is held on June 14 each year, and it commemorates the birthday anniversary of Karl Landsteiner who was awarded the Nobel Prize for his discovery of the ABO blood group system. The global theme of World Blood Donor Day changes each year in recognition of the selfless individuals who donate their blood for people unknown to them. 

The event was organised for the first time in 2004, by four core international organizations: the World Health Organization, the International Federation of Red Cross and Red Crescent Societies; the International Federation of Blood Donor Organizations (IFBDO) and the International Society of Blood Transfusion (ISBT) to raise awareness of the need for safe blood and blood products, and to thank blood donors for their voluntary, life-saving gifts of blood. A blood service that gives patients access to safe blood and blood products in sufficient quantity is a key component of an effective health system.

Contact your national blood bank to find out how you can make contribution.

Representatives of CRIGH were present at the first Global Clinical Trial Forum, organized by the World Health Organization (WHO) in Geneva. The forum gathered stakeholders from all over the globe to put forward a joint vision for sustainable clinical research infrastructure and to strengthen clinical trial capabilities, in alignment with the World Health Assembly’s resolution 75.8:

"Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination."

The forum was attended by over 130 experts from 43 countries, and many more joint the event online. CRIGH participated in the forum representing its clinical trial network and achievements. Throughout the summit, experiences and lessons learned were exchanged among various disciplines and health condition areas. The forum participants called for clinical trial infrastructure, including among others domestic funding, national support for clinical trial infrastructure, improving coordination and streamlining of regulatory and ethics review and approval processes, enhancing patient engagement, and enabling clinical trials with digital and information technologies.

CRIGH is very pleased to announce that the next CRIGH General Assembly will be organised as a hybrid event from 10-15 on Tuesday 7 November 2023 in Paris (France). This event will be organised as a side-event at the EDCTP Forum, which is held in the same venue and will start right after the CRIGH General Assembly.

The CRIGH General Assembly will be held at the Palais des Congrès de Paris in Paris (France), and unites representatives from the global Clinical Research community. The CRIGH Secretary Board has drafted an agenda with keynotes, CRIGH updates and achievements, Regional activities, Work Package presentations, and a presentation / discussion on WHO's WHA 75.8 Resolution. The final agenda will be published shortly.

The European & Developing Countries Clinical Trials Partnership (EDCTP) is organising the eleventh EDCTP Forum from 7-10 November 2023. The Forum will take place at the Palais des Congrès de Paris in Paris (France), and this year’s theme is ‘Partnering for Global Health Research Innovation and Impact in Africa – Celebrating EDCTP: two decades and beyond’. For any further information on the EDCTP Forum, please visit the special website. 

CRIGH is organising its General Assembly back-to-back with the EDCTP event, in the same venue, from 10-15 on Tuesday 7 November.

In honour of the outstanding lifetime achievements of Else Kröner, the founder of the Else Kröner-Fresenius-Stiftung, the foundation has established a major biennial research prize to be awarded in a specified field of biomedical science. The field chosen for 2023 is Diseases of worldwide significance.

Together with the European & Developing Countries Clinical Trials Partnership  (EDCTP), ECRIN hosted a session at the Africa-Europe Science and Innovation Summit on 17 June 2021.  This session brought together key global health actors to collectively discuss lessons learned from the COVID-19 pandemic and the next steps towards the comprehensive mobilization of all stakeholders for building sustainable clinical research preparedness and response capacities. It led to the development of 11 recommendations for capacity building and the development of a clinical research infrastructure in Africa.

The General Assembly of the Clinical Research Initiative for Global Health Consortium (CRIGH) went virtual for its 3rd edition.

The CRIGH Consortium was launched in October 2016, as a follow-up to a prior initiative of the OECD Global Science Forum, to establish a global framework to accelerate international cooperation in non-commercial clinical trials and to promote evidence-based medicine. To date, CRIGH brings together more than 40 international stakeholders across the clinical research value chain on five continents.

This free, self-paced, online course runs from September 1, 2021 to August 1, 2022. Graduate students, post-doctoral scholars, medical, dental, and pharmacy students, scientists, nurses, and other health professionals are encouraged to enrol now.
 

The Good Clinical Trials Collaborative has launched a 6-week public consultation on their guidance for Randomized Controlled Trials (RCTs), ending 30 September.

ECRIN, the European Clinical Research Infrastructure Network, has launched the Covid-19 Marketplace. This new, online tool aims to facilitate and promote collaboration by providing access to planned and ongoing clinical trials, and to share trial ideas and questions in order to enable clinical researchers interested in the same topic to reach out and join forces.

The need for safe and effective COVID-19 treatments requires the capacity to conduct multinational clinical trials to test and compare existing and new therapies and vaccines. In light of this, the OECD published a Policy Response on 4 August 2020: “Greater harmonisation of clinical trial regulations would help the fight against COVID-19”.